Ensuring a more informed and effective oncology drug development process

The rush to discover the next big frontier in cancer medicine is more evident than it ever has been since the introduction of targeted therapies. As a result, there is a healthy pipeline of targeted molecules, all with their own specific mechanisms of action.

However, with this rush comes an increasingly competitive market and the need for quick decisions to be made during the drug development process to differentiate a product’s value from its competitors.

There is a huge demand therefore for a more informed, balanced approach to decision making and implementation during drug development. Quintiles offers a range of services that can help with this process, from navigating evolving scientific and clinical pathways of oncology drug development to connecting companies with oncology leaders to help advance promising compounds.

To view a fact-sheet and learn more about Quintiles’ oncology services, please click here.

For further content relating to the challenges of immuno-oncology trials please click here.